Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
暂无分享，去创建一个
C. Beglinger | A. Straumann | H. Kita | H. Simon | C. Bussmann | Deborah A. Smith | H. Kita | J. Patel | G. Kephart | S. Conus | P. Grzonka | M. Byrne | D. Smith | A. Straumann | Margaret Byrne